Covaxin effectively neutralising double mutant strains: ICMR
A study conducted by the Indian Council of Medical Research (ICMR) has shown the Covaxin developed by Hyderabad-based Bharat Biotech is effective on double mutant strains. Recently, the Central government gave Rs 1,500 crore as an advance to Bharat Biotech to supply Covaxin for the next two to three months. With the fund provided by the Centre, Bharat Biotech is scaling up its Covaxin vaccine production by 70 crore doses per annum. The pharma company has entered into an agreement with the Indian Immunologicals (IIL) to increase the production of Covaxin.